HEMA-NEURO

The hemodynamic management of cerebrovascular diseases is extremely important. Cerebral autoregulation may be impaired in acute stroke and subarachnoid hemorrhage (SAH), and consequently brain perfusion and its oxygenation may be compromised. In these pathologies, cerebral blood flow is extremely sensitive to systemic blood variation, and therefore suboptimal hemodynamic management of these patients may increase ischemic areas, may promote hemorrhagic evolution and develop secondary brain injury.
No clear evidence is available regarding the hemodynamic management and monitoring in this population.

Therefore, the aim of this survey is to investigate the current practice worldwide in hemodynamic management in these clinical conditions.
We would therefore be grateful if you would consider completing this short survey which is designed to understand hemodynamic management of patients with ischemic stroke, hemorrhagic stroke and SAH.

NOTE: To complete this survey you will need some information about patients with diagnosis of ischemic stroke, hemorrhagic stroke and SAH generally admitted to your institution. To answer this query, please consider the generic number of patients before the Covid-19 pandemic to make it representative of the normal situation in your hospital.